Background: The internal N 6 -methyladenosine (m 6 A) modification of cellular mRNA regulates 25 post-transcriptional gene expression. The YTH domain family proteins (YTHDF1-3, or Y1-3) 26 bind to m 6 A-modified cellular mRNA and modulate its metabolism and processing, thereby 27 affecting protein translation in cells. We previously reported that HIV-1 RNA contains m 6 A 28 modification and that Y1-3 proteins inhibit HIV-1 infection by decreasing HIV-1 reverse 29 transcription. Here we extended our studies to further understand the mechanisms of Y1-3-30 mediated inhibition of HIV-1 infection and viral production.
Y1-3 proteins specifically bind to HIV-1 gRNA in infected HeLa/CD4 cells
To confirm Y1-3 binding to HIV-1 gRNA in infected cells, we performed 140 immunoprecipitation (IP) of Y1-3 in HeLa/CD4/Y1-3 cell lines and vector control cells infected 141 with WT HIV-1NL4-3 ( Fig. 3A) . To validate the specificity of Y1-3 binding to HIV-1 RNA, we 142 also included a Y1-3 unrelated cellular protein MAL (MyD88 adapter-like, also known as 143 Toll/IL-1 receptor (TIR) domain-containing adapter protein, or TIRAP) [16, 17] as an additional 144 negative control in the IP assay ( Fig. 3A) . We then quantified the amounts of Y1-3-bound HIV-1 145 gRNA using RT-qPCR assays [13] . We observed that Y1-3 specifically and efficiently bound to 146 WT HIV-1 gRNA in HIV-1NL4-3 infected HeLa/CD4/Y1-3 cells compared with vector control or 147 MAL-expressing cells (Fig. 3B ). The levels of HIV-1 gRNA bound to Y1 appeared higher than 148 those bound to Y2 and Y3 (Fig. 3B ), which could be due to the higher expression of Y1 in 149 HeLa/CD4 cells relative to Y2 and Y3 proteins ( Fig. 3A) and consequently a higher level of IP 150 products (Fig. 3B) . These data confirm that Y1-3 proteins specifically bind to WT HIV-1NL4-3 151 gRNA in infected cells. 152 153 Purified recombinant Y1-3 proteins preferentially bind to an m 6 A-modifed HIV-1 RNA 154 fragment in vitro. 155 Our previous study showed that HIV-1 RNA contains m 6 A modifications at both the 5' and 3' 156 UTR [13] . Given the critical role of the 5' UTR in initiation of HIV-1 reverse transcription, in
The first one is located in the primer-binding site (PBS), and the second is in upstream region of 161 the dimer initiation sequence (DIS) (Fig. 4A ). These two GGACU motifs overlap with m 6 A 162 modifications in HIV-1 gRNA and are close to Y1-3 protein-binding peaks identified in the 5' 163 UTR of HIV-1 gRNA [13] . 164 To study the binding properties of Y1-3 proteins to HIV-1 RNA with m 6 A modification, 165 we synthesized two RNA fragments corresponding to nucleotides 235-281 of HIV-1NL4-3 gRNA 166 with or without m 6 A modification in the second GGACU motif located in the 5' UTR ( Fig. 4A ). 167 To eliminate RNA dimerization in our binding assays, the underlined DIS sequence 168 (AAGCGCGC) was replaced with the nucleotides GAG ( Fig. 4A and 4B ). We first used the 169 AlphaScreen assay [20] to detect interaction of synthesized RNA fragments with purified full-170 length recombinant Y1-3 proteins. Each of these Y1-3 proteins exhibited clear preference for 171 binding to m 6 A-modified HIV-1 RNA than its unmodified counterpart (Fig. 4C ). We further 172 investigated in vitro binding of the RNA fragments to Y1-3 protein using affinity pull-down 173 experiments. Streptavidin-conjugated beads were used to pull-down biotin-modified control or 174 m 6 A RNA fragments. Consistently, at lower Y1-3 concentrations (1-25 nM), clear preferences 175 were seen for binding to m 6 A-modified HIV-1 RNA relative to control RNA, though both RNA 176 fragments had detectable binding to Y1-3 proteins at higher concentrations (125-625 nM) (Fig. 177 4D). The immunoblotting results of the pull-down experiments were quantified and normalized 178 to 1 based on protein pull-down levels by m 6 A RNA fragment at 625 nM protein input (Fig. 4E ). 179 To compare affinity of RNA fragments to Y1-3 proteins, we calculated the concentrations of 180 each Y1-3 protein (ranging from 1-625 nM) required for 50% pull-down levels based on the 181 regression curves ( Fig. 4E and 4F ). The 50% pull-down efficiencies indicated that Y1-3 proteins 182 bound to m 6 A RNA fragment 7-fold, 13-fold, and >20-fold higher than control RNA, 9 respectively ( Fig. 4F ). These results demonstrate that Y1-3 proteins exhibit substantially higher 184 affinity for m 6 A-modified HIV-1 RNA in vitro, which may contribute to Y1-3-mediated 185 inhibition of HIV-1 infection in cells.
187
A to G mutations in GGACU motifs of the 5' UTR of HIV-1 gRNA reduce viral infectivity 188 The two GGACU motifs are located in the PBS and an upstream region of the DIS (Fig.   189 4A), within the m 6 A peaks of the 5' UTR of HIV-1 RNA that were identified in our previous 190 study [13] . Because the 5' UTR is critical for HIV-1 reverse transcription, genome package, and 191 viral infectivity [21, 22] , we further investigated the importance of these m 6 A sites on HIV-1 192 replication and infection by mutagenesis. To eliminate m 6 A modification of the GGACU motifs 193 in HIV-1 gRNA, A to G mutations were introduced in the first (Mut1), second (Mut2), or both 194 GGACT motifs (Mut3) in the HIV-1 proviral DNA plasmid pNL4-3 ( Fig. 5A ). WT pNL4-3 and 195 derived mutants (Mut1-3) were separately transfected into HEK293T cells to measure HIV-1 196 protein expression and viral release. Compared with WT HIV-1, these mutants expressed 197 comparable levels of precursor Gag protein, but the levels of cleaved p24 and intermediate Gag 198 products in cell lysates were 1.4-to 1.8-fold higher ( Fig. 5B ). Consistently, supernatant p24 199 levels of mutant viruses were 1.2-to 1.4-fold higher than that of WT HIV-1 ( Fig. 5C ), suggesting 200 a potential effect of these mutations on Gag proteolytic processing or viral release. To compare 201 the infectivity of the mutants with WT HIV-1, viruses generated in HEK293T cells with equal 202 amounts of p24 were used to infect TZM-bl indicator cells [23] . Interestingly, the infectivity of 203 the mutant viruses was significantly lower (53-74%) relative to WT HIV-1 ( Fig. 5D ), suggesting 204 an important role of these two GGACU motifs in HIV-1 infectivity. 205 Previously published m 6 A mapping results indicate that there are multiple m 6 A sites in 206 different regions of HIV-1 gRNA in addition to the 5' UTR [11] [12] [13] , which can potentially 207 contribute to regulating viral infectivity through interactions with Y1-3 proteins. To address this, 208 we examined whether silencing Y1-3 in target cells could restore the infectivity of these 5' UTR 209 mutant viruses. Endogenous Y1-3 proteins in TZM-bl cells were knocked down by combined 210 Y1-3 specific siRNA, and then TZM-bl cells were infected with the same p24 amount of WT or 211 mutant viruses generated from normal HEK293T cells. In TZM-bl target cells with partial Y1-3 212 proteins knockdown ( Fig. 5E ), all three mutant viruses showed 40-50% lower infectivity relative 213 to WT HIV-1 ( Fig. 5F ). These results confirm the importance of these two GGACU motifs for 214 HIV-1 infectivity, and suggest that other m 6 A sites in HIV-1 RNA can also regulate viral 215 infectivity. 216 Given the important role of the PBS and DIS in structure and function of HIV-1 gRNA 217 [24], we predicted the secondary structures of the RNA segments containing the PBS and DIS of 218 WT and mutant viruses. Compared with the structure of WT HIV-1, the A to G mutation in the 219 first GGACU motif (Mut1) resulted in a longer stem structure in the PBS sequence region, while 220 mutation in the second GGACU motif did not change RNA structure containing the DIS ( To compare the infectivity of HIV-1 generated from cells with Y1-3 knockdown, viruses 238 with equal amounts of p24 were used to infect TZM-bl indicator cells. As shown in Fig. 6C , 239 HIV-1 generated from individual Y1 or Y3 knockdown cells had significantly higher infectivity 240 compared with virus from control cells (P < 0.005), suggesting that Y1 and Y3 proteins in cells 241 negatively affect infectivity of progeny HIV-1. In contrast, efficient Y2 knockdown in virus-242 producing cells resulted in a 25% decrease in HIV-1 infectivity ( Fig. 6A and 6C ), suggesting a 243 different mechanism of Y2-mediated inhibitory effect on viral infection. Moreover, combined 244 Y1-3 knockdown efficiently reduced endogenous levels of Y1-3 proteins in virus-producing cells 245 ( Fig. 6A , last lane), but only modestly increased HIV-1 infectivity ( Fig. 6C ), which were likely 246 due to the different effects resulting from Y1/3 and Y2 knockdown. 
Y1-3 protein knockdown in virus-producing cells decreases HIV-1 Gag expression and

Y1-3 proteins and HIV-1 Gag form a complex with RNAs in HIV-1-infected target cells
To examine whether Y1-3 could interact with any HIV-1 proteins in cells, we performed 250 IP of overexpressed Y1-3 in HEK293T cells co-transfected with pNL4-3, and then detected HIV-251 1 proteins in the input and IP products by immunoblotting using human anti-HIV-1 252 immunoglobulin [25] . Interestingly, we found that Y1-3 co-precipitated with HIV-1 Gag (Pr55) 253 and intermediate Gag products, but not with HIV-1 p24 (Fig. 7 , lanes labeled with IP). The 254 vector cells were used as a negative control for IP and showed a background band of Gag (Pr55) 255 in the IP product ( is conserved in HIV-1 subtype B isolates, but A to G mutations can be found in subtype C and 292 group O isolates (https://www.hiv.lanl.gov/). 293 Compared with WT viruses, mutant viruses harboring A to G mutations have 294 significantly reduced infectivity. We noted that the first GGACU motif is in the PBS and 295 mutation at this site in Mut 1/3 viruses (A to G at nt. 197) introduces a mismatch with tRNA lys 296 primer [32] , which may affect primer annealing and therefore impair viral infectivity. Recent 297 studies showed that the second GGACU motif interacts with HIV-1 nucleocapsid (NC) protein in 298 viral particles [32] , and that nucleotides GGA in this motif strongly bind Gag precursor for viral 299 genome packaging [33] . Mutation at this site may also impair interactions between HIV-1 gRNA 300 and NC protein, contributing to decreased infectivity in mutant viruses. Thus, the decreased 301 infectivity of Mut2 and Mut3 viruses (A to G at nt. 241) may be due to eliminated m 6 A 302 modification at the second GGACU motif and/or decreased interactions between HIV-1 gRNA 303 and Gag/NC. The effects of these mutations on primer binding and Gag/NC interactions remain 304 to be examined. 
